Clinical value of ¹⁸FDG PET/MRI in muscle-invasive, locally advanced, and metastatic bladder cancer.

ABSTRACT:

Objective

Metastatic bladder cancer is an aggressive disease that can often be difficult to diagnose and stage with conventional cross-sectional imaging. The primary objective of this study was to determine the clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose (¹⁸F-FDG) PET/MRI for surveillance and restaging of patients with muscle-invasive, locally advanced, and metastatic bladder cancer compared to conventional imaging methods.

Materials and methods

This retrospective study enrolled patients with muscle-invasive, locally advanced and metastatic bladder cancer in a single institute evaluated with ¹⁸F-FDG PET/MRI. All patients also underwent conventional imaging with CT. Additional imaging may also have included ¹⁸F-FDG PET/CT (¹⁸

SUBMITTER: Civelek AC 

PROVIDER: S-EPMC10211471 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature